Latest news with #ElNasrPharmaceuticalChemicalsCompany
See - Sada Elbalad
2 days ago
- Business
- See - Sada Elbalad
New Dialysis Filter Factory Operates in July, Covering 65% of Domestic Demand
H-Tayea A new dialysis filter factory in Egypt is set to begin operations this July, marking a significant step toward self-sufficiency in medical supplies. The plant, built at a cost of EGP 160m, is expected to cover 65% of the country's local demand and generate annual savings of up to EGP 3bn (approximately $50m) by cutting import costs. Amr Abdel Razek, Chairperson of Wadi El Nile Stio and SLS Egypt, announced at a recent press conference that the factory meets the latest international standards and has received ISO certification. He described the project as a strategic initiative aligned with the state's efforts to strengthen domestic healthcare manufacturing capabilities. Currently, the company imports raw materials from Germany, but Abdel Razek revealed plans to fully localize production within a year. This shift is intended to reduce Egypt's dependence on foreign suppliers and reinforce the national healthcare system. Before this development, Egypt imported about 90% of its dialysis filters. The new facility is expected to reverse that trend significantly. In addition to dialysis filters, Wadi El Nile Stio and SLS Egypt are expanding into the production of critical pharmaceutical products, particularly medications used in intensive care, anesthesia, respiration, and cardiology. Abdel Razek noted that 40% of these drugs are already produced locally in compliance with World Health Organization (WHO) standards, with plans to begin exports to neighboring countries to boost foreign currency inflows. To support this industrial expansion, the companies have partnered with German experts to deliver specialized training programs aimed at transferring technology and upskilling local technical teams. Abdel Razek also announced a plan to launch 22 new pharmaceutical products, priced up to 60% lower than imported equivalents. This aligns with government directives to improve access to affordable, high-quality medication. In collaboration with El Nasr Pharmaceutical Chemicals Company, the firms are rehabilitating production lines for anesthetic drugs and plan to develop additional factories to modernize Egypt's pharmaceutical infrastructure. The new dialysis filters and anesthetic products will be supplied to the Egyptian Unified Procurement Authority. Furthermore, the companies aim to establish maintenance centers for dialysis filters across various governorates and launch a dedicated department to service dialysis machines. This factory is the result of agreements signed in June 2023 between El Nasr Pharmaceutical Chemicals Company and Wadi El Nile Stio Life Science for Pharmaceutical Industries to rehabilitate and operate a previously idle facility. read more Gold prices rise, 21 Karat at EGP 3685 NATO's Role in Israeli-Palestinian Conflict US Expresses 'Strong Opposition' to New Turkish Military Operation in Syria Shoukry Meets Director-General of FAO Lavrov: confrontation bet. nuclear powers must be avoided News Iran Summons French Ambassador over Foreign Minister Remarks News Aboul Gheit Condemns Israeli Escalation in West Bank News Greek PM: Athens Plays Key Role in Improving Energy Security in Region News One Person Injured in Explosion at Ukrainian Embassy in Madrid News China Launches Largest Ever Aircraft Carrier Sports Former Al Zamalek Player Ibrahim Shika Passes away after Long Battle with Cancer Videos & Features Tragedy Overshadows MC Alger Championship Celebration: One Fan Dead, 11 Injured After Stadium Fall Lifestyle Get to Know 2025 Eid Al Adha Prayer Times in Egypt Business Fear & Greed Index Plummets to Lowest Level Ever Recorded amid Global Trade War News Flights suspended at Port Sudan Airport after Drone Attacks Videos & Features Video: Trending Lifestyle TikToker Valeria Márquez Shot Dead during Live Stream News Shell Unveils Cost-Cutting, LNG Growth Plan Technology 50-Year Soviet Spacecraft 'Kosmos 482' Crashes into Indian Ocean News "Tensions Escalate: Iran Probes Allegations of Indian Tech Collaboration with Israeli Intelligence"
Daily News Egypt
3 days ago
- Business
- Daily News Egypt
Egypt to launch new dialysis filter factory in July, covering 65% of domestic demand
A new dialysis filter factory in Egypt is set to begin operations this July, marking a significant step toward self-sufficiency in medical supplies. The plant, built at a cost of EGP 160m, is expected to cover 65% of the country's local demand and generate annual savings of up to EGP 3bn (approximately $50m) by cutting import costs. Amr Abdel Razek, Chairperson of Wadi El Nile Stio and SLS Egypt, announced at a recent press conference that the factory meets the latest international standards and has received ISO certification. He described the project as a strategic initiative aligned with the state's efforts to strengthen domestic healthcare manufacturing capabilities. Currently, the company imports raw materials from Germany, but Abdel Razek revealed plans to fully localize production within a year. This shift is intended to reduce Egypt's dependence on foreign suppliers and reinforce the national healthcare system. Before this development, Egypt imported about 90% of its dialysis filters. The new facility is expected to reverse that trend significantly. In addition to dialysis filters, Wadi El Nile Stio and SLS Egypt are expanding into the production of critical pharmaceutical products, particularly medications used in intensive care, anesthesia, respiration, and cardiology. Abdel Razek noted that 40% of these drugs are already produced locally in compliance with World Health Organization (WHO) standards, with plans to begin exports to neighboring countries to boost foreign currency inflows. To support this industrial expansion, the companies have partnered with German experts to deliver specialized training programs aimed at transferring technology and upskilling local technical teams. Abdel Razek also announced a plan to launch 22 new pharmaceutical products, priced up to 60% lower than imported equivalents. This aligns with government directives to improve access to affordable, high-quality medication. In collaboration with El Nasr Pharmaceutical Chemicals Company, the firms are rehabilitating production lines for anesthetic drugs and plan to develop additional factories to modernize Egypt's pharmaceutical infrastructure. The new dialysis filters and anesthetic products will be supplied to the Egyptian Unified Procurement Authority. Furthermore, the companies aim to establish maintenance centers for dialysis filters across various governorates and launch a dedicated department to service dialysis machines. This factory is the result of agreements signed in June 2023 between El Nasr Pharmaceutical Chemicals Company and Wadi El Nile Stio Life Science for Pharmaceutical Industries to rehabilitate and operate a previously idle facility.
